CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 60 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is 0.19 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11,721 | +2.7% | 1,298 | +28.5% | 0.00% | – |
| Q1 2024 | $11,413 | -37.7% | 1,010 | -56.1% | 0.00% | – |
| Q4 2023 | $18,332 | -7.6% | 2,303 | -24.9% | 0.00% | -100.0% |
| Q3 2023 | $19,837 | -25.0% | 3,066 | -28.2% | 0.00% | 0.0% |
| Q2 2023 | $26,444 | +80033.3% | 4,272 | -50.2% | 0.00% | 0.0% |
| Q1 2023 | $33 | -35.3% | 8,574 | -47.0% | 0.00% | -50.0% |
| Q4 2022 | $51 | -99.8% | 16,171 | +206.4% | 0.00% | – |
| Q3 2022 | $21,000 | +200.0% | 5,277 | +257.3% | 0.00% | – |
| Q2 2022 | $7,000 | -36.4% | 1,477 | +18.6% | 0.00% | – |
| Q1 2022 | $11,000 | +10.0% | 1,245 | +33.9% | 0.00% | – |
| Q4 2021 | $10,000 | +400.0% | 930 | +681.5% | 0.00% | – |
| Q3 2021 | $2,000 | -91.7% | 119 | -89.0% | 0.00% | -100.0% |
| Q2 2021 | $24,000 | – | 1,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $180,267,308 | 53.77% |
| Vida Ventures Advisors, LLC | 3,931,818 | $35,504,317 | 38.83% |
| First Light Asset Management, LLC | 4,780,560 | $43,168,457 | 3.78% |
| Octagon Capital Advisors LP | 2,345,075 | $21,176,027 | 3.33% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $87,426,817 | 2.75% |
| TCG Crossover Management, LLC | 2,890,816 | $26,104,068 | 2.72% |
| 5AM Venture Management, LLC | 1,245,000 | $11,242,350 | 2.52% |
| Exome Asset Management LLC | 274,900 | $2,482,348 | 2.16% |
| EcoR1 Capital, LLC | 5,714,404 | $51,601,068 | 1.58% |
| Affinity Asset Advisors, LLC | 1,135,702 | $10,255,389 | 1.18% |